Of the eight tumor cases with NBS1 mutations, seven (87.5%) had at least one concomitant genetic alteration in the TP53 pathway (P =0.0672, table 3) and three carried TP53 mutations (P =0.0701, table 3). The gene discussed is NBN; the disease is neoplasm.